94.95
Boston Scientific Corp stock is traded at $94.95, with a volume of 6.77M.
It is down -0.48% in the last 24 hours and down -7.56% over the past month.
Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, kidney stone management, cardiac rhythm management, catheter-directed ultrasound imaging, upper gastrointestinal tract diagnostics, interventional oncology, neuromodulation for chronic pain, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for roughly 36% of the firm's total sales.
See More
Previous Close:
$95.41
Open:
$95.13
24h Volume:
6.77M
Relative Volume:
0.82
Market Cap:
$140.69B
Revenue:
$18.49B
Net Income/Loss:
$2.50B
P/E Ratio:
56.51
EPS:
1.6801
Net Cash Flow:
$3.49B
1W Performance:
-1.81%
1M Performance:
-7.56%
6M Performance:
+1.37%
1Y Performance:
+9.01%
Boston Scientific Corp Stock (BSX) Company Profile
Name
Boston Scientific Corp
Sector
Industry
Phone
508-683-4000
Address
300 BOSTON SCIENTIFIC WAY, MARLBOROUGH, MA
Compare BSX with other stocks
Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
---|---|---|---|---|---|---|
![]()
BSX
Boston Scientific Corp
|
94.95 | 141.37B | 18.49B | 2.50B | 3.49B | 1.6801 |
![]()
ABT
Abbott Laboratories
|
131.38 | 230.73B | 43.11B | 13.94B | 6.78B | 7.9963 |
![]()
SYK
Stryker Corp
|
364.92 | 139.39B | 23.82B | 2.92B | 4.02B | 7.5574 |
![]()
MDT
Medtronic Plc
|
95.58 | 122.43B | 34.20B | 4.69B | 5.30B | 3.6218 |
![]()
EW
Edwards Lifesciences Corp
|
72.95 | 43.41B | 5.69B | 1.41B | 577.90M | 6.9828 |
Boston Scientific Corp Stock (BSX) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
Oct-03-25 | Downgrade | Erste Group | Buy → Hold |
Sep-08-25 | Upgrade | Oppenheimer | Perform → Outperform |
Jun-16-25 | Initiated | Leerink Partners | Outperform |
Apr-16-25 | Upgrade | Needham | Hold → Buy |
Jan-10-25 | Upgrade | Deutsche Bank | Hold → Buy |
Oct-18-24 | Downgrade | Needham | Buy → Hold |
May-30-24 | Initiated | Goldman | Buy |
Feb-01-24 | Upgrade | Mizuho | Neutral → Buy |
Jul-19-23 | Initiated | Robert W. Baird | Outperform |
Jun-30-23 | Initiated | CL King | Buy |
May-30-23 | Resumed | Morgan Stanley | Overweight |
Mar-29-23 | Initiated | UBS | Buy |
Dec-22-22 | Initiated | Mizuho | Neutral |
Dec-20-22 | Resumed | Citigroup | Buy |
Oct-18-22 | Initiated | Barclays | Overweight |
Oct-12-22 | Initiated | Jefferies | Buy |
Jul-06-22 | Initiated | Wolfe Research | Outperform |
May-27-22 | Upgrade | Needham | Hold → Buy |
Apr-13-22 | Resumed | Truist | Buy |
Mar-02-22 | Resumed | BofA Securities | Buy |
Dec-10-21 | Initiated | RBC Capital Mkts | Outperform |
May-26-21 | Downgrade | Needham | Buy → Hold |
May-25-21 | Initiated | Barclays | Overweight |
Apr-15-21 | Initiated | Atlantic Equities | Overweight |
Sep-17-20 | Initiated | Truist | Buy |
Sep-11-20 | Initiated | Wolfe Research | Peer Perform |
Apr-22-20 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
Apr-01-20 | Upgrade | Goldman | Neutral → Buy |
Mar-05-20 | Initiated | Citigroup | Buy |
Feb-13-20 | Initiated | Goldman | Neutral |
Feb-06-20 | Resumed | BTIG Research | Buy |
Dec-30-19 | Reiterated | Cowen | Outperform |
Dec-19-19 | Downgrade | Needham | Strong Buy → Buy |
Sep-05-19 | Resumed | JP Morgan | Overweight |
Sep-03-19 | Resumed | Barclays | Overweight |
May-13-19 | Upgrade | Evercore ISI | In-line → Outperform |
Nov-28-18 | Initiated | UBS | Buy |
Oct-16-18 | Initiated | Barclays | Overweight |
Oct-02-18 | Reiterated | Morgan Stanley | Overweight |
Sep-07-18 | Reiterated | Needham | Strong Buy |
Sep-04-18 | Upgrade | Jefferies | Hold → Buy |
Jul-06-18 | Reiterated | Needham | Strong Buy |
Jun-27-18 | Initiated | Bernstein | Outperform |
Apr-26-18 | Reiterated | Needham | Strong Buy |
View All
Boston Scientific Corp Stock (BSX) Latest News
What Fibonacci levels say about Boston Scientific Corporation reboundMarket Activity Summary & Weekly Watchlist for Consistent Profits - newser.com
OFI Invest Asset Management Has $1.38 Million Stock Holdings in Boston Scientific Corporation $BSX - MarketBeat
What You Need To Know Ahead of Boston Scientific's Earnings Release - MSN
Aberdeen Group plc Trims Stock Position in Boston Scientific Corporation $BSX - MarketBeat
Boston Scientific (BSX) Stock Moves -1.92%: What You Should Know - Yahoo Finance
Boston Scientific stock rating reiterated at Buy by TD Cowen - Investing.com
Is Boston Scientific Corporation stock a safe buy pre earningsQuarterly Earnings Report & Low Risk High Reward Trade Ideas - newser.com
November 28th Options Now Available For Boston Scientific (BSX) - Nasdaq
Real time alert setup for Boston Scientific Corporation performance2025 Market WrapUp & AI Based Buy and Sell Signals - newser.com
How to forecast Boston Scientific Corporation trends using time series2025 Market Overview & Risk Managed Investment Entry Signals - newser.com
Boston Scientific: Not In The Most Resolute State As It Approaches Q3 Earnings - Seeking Alpha
Boston Scientific’s SWOT analysis: medtech giant’s stock poised for growth - Investing.com
Shell Asset Management Co. Increases Stock Holdings in Boston Scientific Corporation $BSX - MarketBeat
Boston Scientific Corp. Experiences Evaluation Revision Amidst Market Dynamics and Performance Variability - Markets Mojo
Evercore ISI Revises Boston Scientific (BSX) Price Target to $11 - GuruFocus
Boston Scientific (BSX) Target Price Cut by Evercore ISI Amid Ma - GuruFocus
Boston Scientific (BSX): Evaluating Valuation as Analyst Confidence Remains High Following Strong Segment Growth and Innovation - simplywall.st
What You Need To Know Ahead Of Boston Scientific's Earnings Release - Barchart.com
Why Boston Scientific (BSX) is a Top Growth Stock for the Long-Term - Yahoo Finance
Using data tools to time your Boston Scientific Corporation exitMarket Trend Report & Weekly Stock Breakout Alerts - newser.com
Cullinan Associates Inc. Sells 13,300 Shares of Boston Scientific Corporation $BSX - MarketBeat
Knights of Columbus Asset Advisors LLC Purchases 5,188 Shares of Boston Scientific Corporation $BSX - MarketBeat
A Quick Look at Today's Ratings for Boston Scientific(BSX.US), With a Forecast Between $125 to $136 - 富途牛牛
QRG Capital Management Inc. Grows Position in Boston Scientific Corporation $BSX - MarketBeat
Why Boston Scientific Corporation stock remains on watchlists2025 Geopolitical Influence & Low Risk Entry Point Tips - newser.com
Is Boston Scientific’s Innovation Push in Endoscopy at MEDevice Boston a Sign of R&D Leadership (BSX)? - Yahoo Finance
Penobscot Investment Management Company Inc. Buys 10,177 Shares of Boston Scientific Corporation $BSX - MarketBeat
Jackson Wealth Management LLC Has $4.91 Million Position in Boston Scientific Corporation $BSX - MarketBeat
Empirical Financial Services LLC d.b.a. Empirical Wealth Management Raises Stock Position in Boston Scientific Corporation $BSX - MarketBeat
Mirae Asset Global Investments Co. Ltd. Grows Position in Boston Scientific Corporation $BSX - MarketBeat
Truist Financial Corp Sells 18,116 Shares of Boston Scientific Corporation $BSX - MarketBeat
Sava Infond d.o.o. Has $5.79 Million Stake in Boston Scientific Corporation $BSX - MarketBeat
How Are Analysts Weighing Boston Scientific’s (BSX) Innovation Pipeline Against Market Execution Strategies? - simplywall.st
Down 10.3% in 4 Weeks, Here's Why You Should You Buy the Dip in Boston Scientific (BSX) - Yahoo Finance
Boston Scientific stock rating reiterated at Overweight by Piper Sandler - Investing.com
FY2027 EPS Estimate for Boston Scientific Boosted by Analyst - MarketBeat
The Zacks Analyst Blog Highlights Boston Scientific, Union Pacific, Realty Income and Weyco - sharewise.com
Boston Scientific stock rating downgraded to Hold by Erste Group - Investing.com
RBC Capital Maintains a Buy on Boston Scientific Corporation (BSX) With a $125 PT - Insider Monkey
Consolidated Portfolio Review Corp Acquires Shares of 3,136 Boston Scientific Corporation $BSX - MarketBeat
How Boston Scientific Corporation stock benefits from digital adoptionEarnings Risk Report & Detailed Earnings Play Alerts - newser.com
Top Research Reports for Boston Scientific, Union Pacific & Realty Income - Yahoo Finance
Oppenheimer Sticks to Their Buy Rating for Boston Scientific (BSX) - The Globe and Mail
Leerink Partners Reaffirms Their Buy Rating on Boston Scientific (BSX) - The Globe and Mail
Truist Financial Sticks to Their Buy Rating for Boston Scientific (BSX) - The Globe and Mail
27,070 Shares in Boston Scientific Corporation $BSX Bought by Lecap Asset Management Ltd. - MarketBeat
Boston Scientific aims for market leadership in electrophysiology - Yahoo Finance
Boston Scientific (NYSE:BSX) Receives “Buy” Rating from Needham & Company LLC - Defense World
Boston Scientific (NYSE:BSX) Price Target Raised to $129.00 at Truist Financial - Defense World
Boston Scientific (BSX) Stock Dips While Market Gains: Key Facts - Yahoo Finance
Boston Sci closes Elutia deal, projects 10% growth through 2028 - BioWorld MedTech
Boston Scientific Corp Stock (BSX) Financials Data
Revenue
Net Income
Cash Flow
EPS
Boston Scientific Corp Stock (BSX) Insider Trading
Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
---|---|---|---|---|---|---|---|
Fitzgerald Joseph Michael | EVP & Group Pres, Cardiology |
Oct 01 '25 |
Sale |
98.47 |
50,000 |
4,923,327 |
178,342 |
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):